Acetylation of interferon regulatory factor-5 suppresses androgen receptor and downregulates expression of Sox2

Hilal Acidereli1,2, Fatma Aysun Turut1, Ozge Cevik3

  • 1Department of Biochemistry, Faculty of Pharmacy, Cumhuriyet University, Sivas, Turkey.

Insights

Interferon regulatory factor-5 (IRF5) acts as a tumor suppressor in prostate cancer. Its expression is linked to androgen receptor signaling and stem cell factors, with lower levels correlating to advanced disease stages.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Interferon regulatory factor-5 (IRF5) is a transcription factor with tumor suppressor functions.
  • IRF5's role in prostate cancer and its regulatory mechanisms are not well understood.
  • Dysregulated IRF5 protein function is observed in various human cancers.

Purpose of the Study:

  • To investigate the role and regulatory mechanisms of IRF5 in prostate cancer.
  • To explore the interaction between IRF5, androgen receptor (AR) signaling, and stem cell factors in prostate cancer.
  • To determine the potential of IRF5 as a therapeutic target for prostate cancer.

Main Methods:

  • Utilized human prostate cancer cell lines (PC3, DU145, LNCaP) and clinical samples.
  • Employed immunofluorescence staining, co-immunoprecipitation, and ChIP assays to assess protein interactions.
  • Performed luciferase assays to analyze target gene regulation by IRF5, AR, and other factors.

Main Results:

  • IRF5 expression is significantly lower in androgen-dependent prostate cancer cells and tissues.
  • IRF5 expression is down-regulated in advanced stages of prostate tumors, indicating a pathological role.
  • IRF5 interacts with AR signaling and stem cell factors (Nanog, Oct4, Sox2), influencing AR acetylation and cellular signaling pathways.

Conclusions:

  • IRF5 plays a crucial role in prostate cancer, acting as a tumor suppressor.
  • IRF5 expression is regulated by AR signaling and stem cell factors in prostate cancer.
  • IRF5 represents a promising therapeutic target for androgen-dependent prostate cancers.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

2.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K
Master Transcription Regulators02:23

Master Transcription Regulators

2.5K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.4K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.1K